UBL sees India as key growth engine for Heineken; focuses on premiumisation, margin expansion

United Breweries Ltd sees India as central to Heineken’s growth agenda. The Indian market is experiencing rising premiumisation and offers significant expansion opportunities. Heineken NV plans to expand Ebitda margins in India over the medium term. The company highlights its strong brand portfolio and 100 percent localisation of requirements. State-level reforms are accelerating category growth…

Cohance Lifesciences to invest USD 18 mn in NJ Bio, Aruka Bio

Cohance Lifesciences announced an eighteen million dollar investment to strengthen its antibody-drug conjugate strategy. This includes thirteen million dollars for NJ Bio, increasing Cohance’s ownership to sixty-seven point three percent. An additional five million dollars will give Cohance a sixty-five percent stake in Aruka Bio. These transactions aim to integrate NJ Bio’s services with Cohance’s…